CONFOMETRX, INC.
Biotech · Private
Small molecule drug candidates targeting GPR75 for obesity management
- Grants
- $7.0M
- 14 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 1 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20152017201920212023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Structure-based Drug Discovery for the GLP-1 Receptor | $249,003 | |
| Federal grant | Department of Health and Human Services · Phase II · Structure-based Drug Discovery for the GLP-1 Receptor | $467,338 | |
| Federal grant | Department of Health and Human Services · Phase II · Structure-based discovery of dopamine D1 receptor selective small molecule ligands | $376,468 | |
| Federal grant | Department of Health and Human Services · Phase I · Structure-based drug discovery for Dopamine D2 Receptor Selective Ligands | $193,685 | |
| Federal grant | Department of Health and Human Services · Phase II · Structure-based Drug Discovery for the GLP-1 Receptor | $494,338 | |
| Federal grant | Department of Health and Human Services · Phase II · Structure-based discovery of dopamine D1 receptor selective small molecule ligands | $381,468 | |
| Federal grant | Department of Health and Human Services · Phase II · Structure-based discovery of dopamine D1 receptor selective small molecule ligands | $676,062 | |
| Federal grant | Department of Health and Human Services · Phase II · Structure-based drug discovery for Dopamine D2 Receptor Selective Ligands | $659,183 | |
| Federal grant | Department of Health and Human Services · Phase II · Structure-based discovery of dopamine D1 receptor selective small molecule ligands | $676,062 | |
| Federal grant | Department of Health and Human Services · Phase II · Structure-based drug discovery for Dopamine D2 Receptor Selective Ligands | $764,531 | |
| Federal grant | Department of Health and Human Services · Phase II · Structure-based discovery of dopamine D1 receptor selective small molecule ligands | $676,062 | |
| Federal grant | Department of Health and Human Services · Phase II · Structure-based drug discovery for Dopamine D2 Receptor Selective Ligands | $738,119 | |
| Federal grant | Department of Health and Human Services · Phase I · Discovery of GPR75 small molecule ligands for the treatment of obesity | $303,375 | |
| Federal grant | Department of Health and Human Services · Phase I · Discovery of GPR171 small molecule ligands for the treatment of chronic pain | $298,313 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1304 | LUNG THERAPEUTICS INC | — | — |
| 1305 | Immunomedics | — | — |
| 1306 | INVENIO THERAPEUTICS INC | — | — |
| 1307 | CONFOMETRX, INC. | — | — |
| 1308 | Cavatar LLC | — | — |
| 1309 | COARE BIOTECHNOLOGY, INC. | — | — |
| 1310 | Pinnacle Medicines | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Method For Analyzing The Three Dimensional Structure Of A Gpcrapplication
- Gpcr Comprising An IC2 Insertiongranted
- Method And Composition For Crystallizing A Family C Gpcrapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.